There are 105 resources available
EONS Safety work: Where do we go from here?
Presenter: Matthew Fowler
Session: EONS13: Quality and safety of cancer nursing
Resources:
Webcast
Novice Research Dissemination Award 1: Abstract CN42: Nurse and pharmacist-delivered gynaecology telephone clinic: maintenance therapies patient and staff survey
Presenter: Philippa Jupp
Session: EONS13: Quality and safety of cancer nursing
Resources:
Slides
Webcast
Invited Discussant LBA32 and 807O
Presenter: Ana Oaknin
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Isabelle Ray-Coquard
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Webcast
CN10 - Cancer nursing education and recognition in Europe: A survey by the European Oncology Nursing Society
Presenter: Patrick Crombez
Session: EONS13: Quality and safety of cancer nursing
Resources:
Abstract
Slides
Webcast
CN21 - Patient and occupational safety in Europe: A survey by the European Oncology Nursing Society
Presenter: Helena Ullgren
Session: EONS13: Quality and safety of cancer nursing
Resources:
Abstract
Slides
Webcast
CN9 - The European Cancer Nursing Index 2020: A tool for mapping cancer nursing status across Europe
Presenter: Lena Sharp
Session: EONS13: Quality and safety of cancer nursing
Resources:
Abstract
Slides
Webcast
LBA6_PR - Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study
Presenter: Markus Moehler
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast
LBA7_PR - Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study
Presenter: Narikazu Boku
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast
LBA8_PR - Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study
Presenter: Ken Kato
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast